CONTENTS:
- Outcomes of physicians with substance use disorders in state physician health programs: A narrative review. Goldenberg M.D., Miotto K.M., Skipper G.M., Sanford J.B., p. 195-202.
- Sleeping patterns in patients with opioid use disorder: Effects of opioid maintenance treatment and detoxification. Chrobok A.I., Krause D., Winter C., Plörer D., Martin G., Koller G., et al., p. 203-210.
- Overcoming heroin addiction without the use of pharmaceuticals: A qualitative interview study. Nehlin C., Willebrand M., Brander C.W., Öster C., p. 211-217.
- Older-adult marijuana users in substance use treatment: Characteristics associated with treatment completion. Choi N.G., DiNitto D.M., p. 218-227.
- Associations between psychiatric disorders and cannabis-related disorders documented in electronic health records. Campbell A., Bailey S.R., Hoffman K.A., Ponce-Terashima J., Fankhauser K., Marino M., et al., p. 228-236.
- Uses, effects and toxicity of synthetic cannabinoids from the perspective of people with lived experiences. Assi S., Marshall D., Bersani F.S., Corazza O., p. 237-247.
- Learning approaches and attitudes toward cognitive enhancers in UK university students. Adamopoulos P., Ho H., Sykes G., Szekely P., Dommett E.J., p. 248-254.
- Ayahuasca users in Estonia: Ceremonial practices, subjective long-term effects, mental health, and quality of life. Kaasik H., Kreegipuu K., p. 255-263.
- Personality traits in former Spanish substance users recovered with ayahuasca. Apud Pelaez I.E., p. 264-272.
- Use of benefit enhancement strategies among 5-Methoxy-N,N-Dimethyltryptamine (5-MeO-DMT) users: Associations with mystical, challenging, and enduring effects. Lancelotta R.L., Davis A.K., p. 273-281.
- Public perceptions toward kratom (Mitragyna speciosa) use in Malaysia. Singh D., Narayanan S., Suraya S., Saref A., Grundmann O., Prozialeck W.C., et al., p. 282-288.